Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 1
1973 1
1974 2
1975 24
1976 32
1977 20
1978 17
1979 16
1980 12
1981 17
1982 13
1983 7
1984 21
1985 18
1986 26
1987 25
1988 29
1989 51
1990 39
1991 47
1992 35
1993 42
1994 48
1995 37
1996 30
1997 21
1998 36
1999 30
2000 27
2001 23
2002 18
2003 28
2004 14
2005 19
2006 12
2007 11
2008 9
2009 5
2010 8
2011 6
2012 8
2013 10
2014 11
2015 4
2016 9
2017 7
2018 2
2019 6
2020 3
2021 1
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

928 results

Results by year

Filters applied: . Clear all
Page 1
Mazindol: a risk factor for pulmonary arterial hypertension?
Konofal E, Benzouid C, Delclaux C, Lecendreux M, Hussey E. Konofal E, et al. Sleep Med. 2017 Jun;34:168-169. doi: 10.1016/j.sleep.2017.02.020. Epub 2017 Mar 18. Sleep Med. 2017. PMID: 28522087 Review.
Despite the use of mazindol for decades, reports of PAH due to mazindol intake have been extremely rare. Recent interest on mazindol has emerged for the treatment of narcolepsy and attention-deficit/hyperactivity disorder. ...
Despite the use of mazindol for decades, reports of PAH due to mazindol intake have been extremely rare. Recent interest on …
[Mazindol].
Mori Y. Mori Y. Nihon Rinsho. 2011 Jan;69 Suppl 1:683-6. Nihon Rinsho. 2011. PMID: 21766681 Review. Japanese. No abstract available.
Clinical studies with mazindol.
Inoue S. Inoue S. Obes Res. 1995 Nov;3 Suppl 4:549S-552S. doi: 10.1002/j.1550-8528.1995.tb00226.x. Obes Res. 1995. PMID: 8697057 Free article. Review.
Combined use of mazindol with VLCD made the VLCD therapy more effective in outpatients. Two of 3 patients with Prader-Willi syndrome inhibited their body weight gain with mazindol. Thus, mazindol produced positive effects in these studies, although the effect …
Combined use of mazindol with VLCD made the VLCD therapy more effective in outpatients. Two of 3 patients with Prader-Willi syndrome …
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.
Lucchetta RC, Riveros BS, Pontarolo R, Radominski RB, Otuki MF, Fernandez-Llimos F, Correr CJ. Lucchetta RC, et al. Clinics (Sao Paulo). 2017 May;72(5):317-324. doi: 10.6061/clinics/2017(05)10. Clinics (Sao Paulo). 2017. PMID: 28591345 Free PMC article. Review.
The aim of this study was to evaluate efficacy and safety of amfepramone, fenproporex and mazindol as a monotherapy for the treatment of obese or overweight patients. ...These results corroborated the finding that the efficacy of amfepramone is greater than that of placebo …
The aim of this study was to evaluate efficacy and safety of amfepramone, fenproporex and mazindol as a monotherapy for the treatment …
Mazindol-induced lithium toxicity.
Hendy MS, Dove AF, Arblaster PG. Hendy MS, et al. Br Med J. 1980 Mar 8;280(6215):684-5. doi: 10.1136/bmj.280.6215.684-a. Br Med J. 1980. PMID: 7363020 Free PMC article. No abstract available.
Clinical and basic aspects of an anorexiant, mazindol, as an antiobesity agent in Japan.
Inoue S, Egawa M, Satoh S, Saito M, Suzuki H, Kumahara Y, Abe M, Kumagai A, Goto Y, Shizume K. Inoue S, et al. Am J Clin Nutr. 1992 Jan;55(1 Suppl):199S-202S. doi: 10.1093/ajcn/55.1.199s. Am J Clin Nutr. 1992. PMID: 1728834 Review.
The Japanese Mazindol study group investigated the action of an anorexiant, mazindol, and found that it reduced food intake by directly suppressing neurons in the lateral hypothalamus, inhibited gastric acid secretion, increased motor activity, decreased glucose abs …
The Japanese Mazindol study group investigated the action of an anorexiant, mazindol, and found that it reduced food intake by …
Efficacy and safety of the metformin-mazindol anorectic combination in rat.
Argüelles-Tello F, Roa-Coria JE, Zúñiga-Romero Á, Huerta-Cruz JC, Quiñonez-Bastidas GN, Flores-Murrieta FJ, Rocha-González HI, Reyes-García JG. Argüelles-Tello F, et al. Acta Pharm. 2021 Jun 1;71(2):279-291. doi: 10.2478/acph-2021-0019. Acta Pharm. 2021. PMID: 33151165 Free article.
The current study investigates the anorectic interaction and safety of the mazindol-metformin combination in rats. Isobologram and interaction index were used to determine anorectic interaction between mazindol and metformin in the sweetened milk model. ...Mazind …
The current study investigates the anorectic interaction and safety of the mazindol-metformin combination in rats. Isobologram and in …
Diethylpropion and mazindol: An end to the discussion?
Lucchetta RC, Riveros BS, Pontarolo R, Radominski RB, Otuki MF, Fernandez-Llimos F, Correr CJ. Lucchetta RC, et al. Rev Assoc Med Bras (1992). 2017 Mar;63(3):203-206. doi: 10.1590/1806-9282.63.03.203. Rev Assoc Med Bras (1992). 2017. PMID: 28489121 Free article.
Therefore, the country was the scene of a debate that divided the Brazilian Health Surveillance Agency (Anvisa - Agencia Nacional de Vigilancia Sanitaria) and medical societies over the maintenance record of diethylpropion, mazindol and fenproporex. In this context, this c …
Therefore, the country was the scene of a debate that divided the Brazilian Health Surveillance Agency (Anvisa - Agencia Nacional de Vigilan …
Mazindol.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1982 Oct 29;24(621):98. Med Lett Drugs Ther. 1982. PMID: 7144688 No abstract available.
Mazindol in the treatment of narcolepsy.
Parkes JD, Schachter M. Parkes JD, et al. Acta Neurol Scand. 1979 Oct;60(4):250-4. doi: 10.1111/j.1600-0404.1979.tb02976.x. Acta Neurol Scand. 1979. PMID: 525256
The response to mazindol was excellent in six subjects, good in 14, moderate in 12 and poor in two. No cardiovascular effects, haematological toxicity, tolerance or dependence occurred. Mazindol 6 mg had the same effect on narcolepsy as d-amphetamine 50 mg, but caus …
The response to mazindol was excellent in six subjects, good in 14, moderate in 12 and poor in two. No cardiovascular effects, haemat …
928 results